Heartflow (NASDAQ:HTFL) Upgraded by Robert W. Baird to “Strong-Buy” Rating

Posted by Geri Gentry on Aug 1st, 2026

Heartflow (NASDAQ:HTFL – Get Free Report) was upgraded by stock analysts at Robert W. Baird to a “strong-buy” rating in a research report issued to clients and investors on Friday,Zacks.com reports.

HTFL has been the topic of several other reports. Weiss Ratings lowered shares of Heartflow from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, July 8th. Canaccord Genuity Group cut their price objective on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research report on Friday, May 15th. William Blair started coverage on Heartflow in a research note on Monday, May 4th. They set an “outperform” rating on the stock. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a research note on Tuesday, June 30th. Finally, Wells Fargo & Company lifted their price target on shares of Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $36.57.

Read Our Latest Analysis on Heartflow

Heartflow Stock Down 2.3%

Shares of Heartflow stock opened at $25.23 on Friday. Heartflow has a 52-week low of $20.13 and a 52-week high of $41.22. The company’s 50-day simple moving average is $29.02 and its 200-day simple moving average is $28.10. The firm has a market cap of $2.18 billion and a price-to-earnings ratio of -8.11.

Heartflow (NASDAQ:HTFL – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. Heartflow’s revenue was up 41.3% on a year-over-year basis. Equities research analysts anticipate that Heartflow will post -0.82 EPS for the current year.

Insider Transactions at Heartflow

In other news, insider Campbell Rogers sold 9,219 shares of the firm’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $28.34, for a total transaction of $261,266.46. Following the completion of the sale, the insider directly owned 78,731 shares in the company, valued at $2,231,236.54. This trade represents a 10.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 38,900 shares of Heartflow stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00. Following the sale, the chief executive officer directly owned 457,935 shares in the company, valued at approximately $16,027,725. The trade was a 7.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 115,805 shares of company stock worth $3,548,884. 7.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Heartflow

Hedge funds have recently bought and sold shares of the business. Seven Grand Managers LLC lifted its holdings in Heartflow by 100.0% in the fourth quarter. Seven Grand Managers LLC now owns 100,000 shares of the company’s stock worth $2,915,000 after acquiring an additional 50,000 shares during the last quarter. XXEC Inc. grew its holdings in shares of Heartflow by 564.8% during the first quarter. XXEC Inc. now owns 278,681 shares of the company’s stock valued at $6,780,000 after purchasing an additional 236,761 shares during the last quarter. UBS Group AG raised its position in shares of Heartflow by 228.8% during the 4th quarter. UBS Group AG now owns 501,165 shares of the company’s stock worth $14,609,000 after purchasing an additional 348,753 shares during the period. Rock Springs Capital Management LP lifted its holdings in shares of Heartflow by 106.2% in the 1st quarter. Rock Springs Capital Management LP now owns 572,500 shares of the company’s stock worth $13,929,000 after purchasing an additional 294,800 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in Heartflow by 8.8% during the 4th quarter. Vanguard Group Inc. now owns 1,580,313 shares of the company’s stock valued at $46,066,000 after purchasing an additional 128,400 shares during the period.

About Heartflow

(Get Free Report)

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.